| GTO ID | GTC3310 |
| Trial ID | NCT05686720 |
| Disease | Triple-Receptor Negative Breast Cancer |
| Therapy | CAR-NK cell |
| Treatment | SZ011 |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer |
| Year | 2023 |
| Country | China |
| Company sponsor | First Affiliated Hospital of Shantou University Medical College |
| Other ID(s) | PCZCTP-220702-001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||